Caroline Helwick

MRI
Breast MRI pinpoints residual disease after chemotherapy
Breast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.
December 18, 2008
Page 1 of 1
Top Stories
Top 10 Gold Social
Clinical News
Body composition analysis, MRI safety topped 2024's most read articles
While COVID and radiology salaries hit the top of AuntMinnie.com's Top 10 most-read posts of 2023, they rounded out the bottom of this year's list.
Neiman Hpi
Practice Management
Neiman index outperforms Charlson for predicting imaging use
Mammogram Patient
Womens Imaging
40% of women in their 40s forgo biennial breast cancer screening
Corporate Transparency
Risk Management
Practices must comply with the Corporate Transparency Act
Kidneys
Nuclear Medicine
Kidneys appear to tolerate Lu-177 treatments
More in Home
Body composition analysis, MRI safety topped 2024's most read articles
By Liz Carey
While COVID and radiology salaries hit the top of AuntMinnie.com's Top 10 most-read posts of 2023, they rounded out the bottom of this year's list.
December 20, 2024
Top 10 Gold Social
Neiman index outperforms Charlson for predicting imaging use
By Kate Madden Yee
The Neiman Imaging Comorbidity Index outperforms the Charlson Comorbidity Index for predicting advanced imaging use.
December 20, 2024
Neiman Hpi
40% of women in their 40s forgo biennial breast cancer screening
By Amerigo Allegretto
About two in every five women in their 40s do not undergo biennial breast cancer screening per USPSTF recommendations.
December 20, 2024
Mammogram Patient
Practices must comply with the Corporate Transparency Act
By Healthcare Administrative Partners
A new column from Healthcare Administrative Partners discusses the impact of the Corporate Transparency Act on medical practices.
December 20, 2024
Corporate Transparency
Kidneys appear to tolerate Lu-177 treatments
By Will Morton
Kidney-absorbed doses of lutetium-177 (Lu-177)-based treatments for prostate cancer and neuroendocrine tumors appear to be below toxicity thresholds.
December 19, 2024
Kidneys
Higher Medicaid-to-Medicare reimbursement ratios boost imaging use
By Kate Madden Yee
Higher Medicaid-to-Medicare reimbursement ratios are linked to increased likelihood of Medicaid patients receiving CT, MR, ultrasound, and x-ray imaging.
December 19, 2024
Money Hundred Bills
AI algorithm 'harmonizes' brain MRI data from different scanners
By Kate Madden Yee
A novel machine-learning algorithm used with MRI can harmonize brain volumetric data of patients undergoing Alzheimer's disease assessment gathered from different scanners.
December 18, 2024
Mri Brain Head
Recommendations address AI bias, data transparency
By Amerigo Allegretto
New recommendations seek to make medical AI safe and effective for everyone by tackling the issues of bias and transparency.
December 18, 2024
Artificial Intelligence Ai Suit
AdvaMed applauds House Task Force on AI report
By AuntMinnie.com staff writers
AdvaMed commended the end-of-year report submitted to the U.S. Congress on December 17 by the House Task Force on AI.
December 18, 2024
Artificial Intelligence Ai Abstract 400
African American men respond more favorably to Ra-223 therapy
By Will Morton
African American men with metastatic castrate-resistant prostate cancer may respond more favorably than white men to treatment with radium-223.
December 17, 2024
Prostate Imaging
What radiology trainees should know heading into 2025
By Liz Carey
Radiologists discuss specialty and job market: 10 takeaways.
December 17, 2024
Radiology Practice Models 2024
Solis acquires San Antonio, TX imaging centers
By AuntMinnie.com staff writers
Solis Mammography has acquired Avestēe Women's Imaging Centers in San Antonio, TX.
December 16, 2024
Breast Screening Mammo
Page 1 of 107
Next Page